600645 Vcanbio Cell & Gene Engineering Corp.,Ltd.
- 17.54
- -0.67-3.68%
Vcanbio Cell & Gene Engineering Corp.,Ltd. News
Notice of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on convening the first extraordinary shareholders\' meeting in 2024
Announcement of Zhongyuan Union Cell Genetic Engineering Co., Ltd. on the appointment of an accounting firm
Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on the wholly-owned subsidiary obtaining a notice of approval for drug clinical trials
Announcement of Resolutions of the 13th Interim Board Meeting of the 11th Zhongyuan Union Cytogenetic Engineering Co., Ltd.
Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on the replacement of the sponsor of the financial advisor for continuous supervision
Special report on the storage and actual use of funds raised by Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. for the 2024 semi-annual period
Announcement of Resolutions of the 12th Board Meeting of the 11th Zhongyuan Union Cytogenetic Engineering Co., Ltd.
Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on participating in the 2024 semi-annual report performance briefing for listed companies in Tianjin and an online investor reception day
Announcement of Resolutions of the 5th Meeting of the 11th Supervisory Committee of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. 2024 Semi-Annual Report
Summary of the 2024 semi-annual report of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd.
The selection system for accounting firms of Vcanbio Cell & Gene Engineering Corp., Ltd.
Announcement of the resolution of the 11th extraordinary meeting of the 11th board of directors of Vcanbio Cell & Gene Engineering Corp., Ltd.
Announcement of the results of share repurchase and share changes by vcanbio cell & gene engineering corp.,ltd.
Announcement on the Progress of Share Repurchase by vcanbio cell & gene engineering corp.,ltd.
Announcement on the Progress of Share Repurchase by vcanbio cell & gene engineering corp.,ltd.
Announcement of vcanbio cell & gene engineering corp.,ltd. obtaining acceptance notice for pharmaceutical clinical trial application by its wholly-owned subsidiary.
Announcement of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on the progress of share repurchase
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
Legal Opinion of Beijing Guofeng Law Firm on the 2023 Annual General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
Analysis
Price Target
No Data
